Overview

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

Status:
Completed

Trial end date:
2021-08-16

Target enrollment:

Participant gender:

Summary

An open-label clinical study of the pharmacokinetics and safety of Elsulfavirine, 200 mg tablets, with single and multiple oral administration in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Viriom

Treatments:

Elsulfavirine